Related Experiment Videos
Peripheral Blood Stem Cells: Transplantation and Beyond.
1Division of Haematology, Hanson Centre for Cancer Research, Institute of Medical and Veterinary Science, Adelaide SA 5000, Australia.
The Oncologist
|January 1, 1997
Summary
Peripheral blood stem cell transplantation (PBSCT) offers faster recovery and lower costs than traditional bone marrow transplants. This method is expanding to include allogeneic and cord blood cells, improving donor availability and enabling new cancer therapies.
Area of Science:
- Hematology
- Oncology
- Stem Cell Transplantation
Background:
- Peripheral blood stem cells (PBSCs) are increasingly utilized for transplantation.
- Peripheral blood stem cell transplantation (PBSCT) shows advantages over conventional bone marrow transplantation.
- PBSCT offers earlier hematopoietic recovery, reduced morbidity, and improved cost-effectiveness.
Purpose of the Study:
- To review the current clinical practices in PBSCT.
- To discuss future developments and applications of PBSCT.
- To highlight the benefits and expanding use of PBSCT in hematological and oncological conditions.
Main Methods:
- Review of clinical results and outcomes of PBSCT.
- Discussion of advancements in cytokine research and ex vivo manipulation of stem cells.
- Exploration of the use of allogeneic and cord blood cells in PBSCT.
Main Results:
- PBSCT demonstrates earlier hematopoietic recovery and lower morbidity.
- Multicycle transplantation is viable for malignancies, allowing dose-escalated chemotherapy.
- Allogeneic and cord blood PBSCT show encouraging results, enhancing donor availability.
Conclusions:
- PBSCT is a major source of hematopoietic stem cells for transplantation.
- Future developments include ex vivo manipulation for anticancer treatments and potential use in nonmalignant diseases.
- PBSCT represents a significant advancement in transplantation medicine with broad applicability.